| Symbol: | 
  	  
	  SPG21
	   | 
      
	  
      
  	  | Description: | 
  	  
	  
	  spastic paraplegia 21 (autosomal recessive, Mast syndrome) [Source:HGNC Symbol;Acc:20373]
	  
	   | 
      
      
  	  | Location: | 
  	  
	  Chr15:65255362-65282648[-]
	   | 
      
	  
         
	   
       | CRmiRSNP:
	   
		
	   ~ Export ~
	    
	    | 
      	
      	
      		Records:null
      		 
      			
      			
      				| Compound | 
					CRmiRSNP | 
					SNP_sig | 
					Model | 
					Molecule | 
					Mol_sig | 
					Type | 
      			 
      			
      			
      		 	
      		
      		
      			Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant 
				Total:0 Current:1 
      			[First] [Prev] [Next] [Last] 
      		 
      	 | 
      
	  
	  
	  
       | Compound:
	    
		
	    ~ Export ~
	   
		
	    | 
	  
      	
      	
      		Records:191			
      		 
      			
      				| Gene | 
					Compound | 
      				Gen_sig | 
					Exp_pattern | 
      			 
      		    
      			
      			
				    | SPG21 | 
					6H-Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- | 
      				0.044 | 
      				Up | 
      			 
      				
      			
      			
				    | SPG21 | 
					NSC 105348 | 
      				0.044 | 
      				Up | 
      			 
      				
      			
      			
				    | SPG21 | 
					Thiothixene | 
      				0.014 | 
      				Down | 
      			 
      				
      			
      			
				    | SPG21 | 
					Lobinaline, monohydrochloride | 
      				0.004 | 
      				Down | 
      			 
      				
      			
      			
				    | SPG21 | 
					NSC 112789 | 
      				0.044 | 
      				Down | 
      			 
      				
      			
      			
				    | SPG21 | 
					NSC 116532 | 
      				0.004 | 
      				Down | 
      			 
      				
      			
      			
				    | SPG21 | 
					NSC 11850 | 
      				0.011 | 
      				Down | 
      			 
      				
      			
      			
				    | SPG21 | 
					Guanidine, 1-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-3-[4-[[2-(diisopropylamino)ethyl]amino]-6-methyl-2-pyrimidinyl]- | 
      				0.03 | 
      				Down | 
      			 
      				
      			
      			
				    | SPG21 | 
					NSC 128166 | 
      				0.004 | 
      				Down | 
      			 
      				
      			
      			
				    | SPG21 | 
					NSC 13477 | 
      				0.001 | 
      				Down | 
      			 
      				
      			
      			
				    | SPG21 | 
					Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) | 
      				0.003 | 
      				Down | 
      			 
      				
      			
      			
				    | SPG21 | 
					Benzamide, N-[2-(diethylamino)ethyl]-4-methyl-2-nitro- 3-(phenylmethoxy)- | 
      				0.011 | 
      				Down | 
      			 
      				
      			
      			
				    | SPG21 | 
					NSC 15795 | 
      				0.007 | 
      				Down | 
      			 
      				
      			
      			
				    | SPG21 | 
					NSC 16857 | 
      				0.013 | 
      				Down | 
      			 
      				
      			
      			
				    | SPG21 | 
					Pimozide | 
      				0.023 | 
      				Down | 
      			 
      					
      		 
			
			 Expression pattern: Sensitivity / Resistance 
      			Total:13 Current:1 
      			[First] [Prev]  Next Last 
      		  	
      	 | 
      
	   
	  
       | SNP:
	   
		
	    ~ Export ~
	   
	    | 
      	
      	
      		Records:11
      		 	
			
      			Total:1 Current:1 
      			[First] [Prev] [Next] [Last] 
      		 		
      	 | 
      
	  
	  
	  
       | miRNA:
	   
		
	    ~ Export ~
	    
	    | 
      	
      	
      		Records:63
      		 
			
      			Total:5 Current:1 
      			[First] [Prev]  Next Last 
      		  		
      	 |